Picato ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

picato

leo laboratories ltd. - ingenol mebutate - keratose, actinic - antibiotika og chemotherapeutics for dermatologisk bruk, andre chemotherapeutics - picato er indikert for kutan behandling av ikke‑hyperkeratotic, ikke‑hypertrofisk aktinisk keratose i voksne.

Diprosalic 0.5 mg/ g / 30 mg/ g নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

diprosalic 0.5 mg/ g / 30 mg/ g

n.v. organon - kloosterstraat - betametasondipropionat / salisylsyre - salve - 0.5 mg/ g / 30 mg/ g

Diprosalic 0.5 mg/ g / 20 mg/ g নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

diprosalic 0.5 mg/ g / 20 mg/ g

n.v. organon - kloosterstraat - betametasondipropionat / salisylsyre - liniment, oppløsning - 0.5 mg/ g / 20 mg/ g

Flutide Nasal 1 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

flutide nasal 1 mg/ ml

glaxosmithkline as - flutikasonpropionat - nesedråper, suspensjon - 1 mg/ ml

Imigran 20 mg/ dose নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

imigran 20 mg/ dose

glaxosmithkline as - sumatriptansuksinat - nesespray, oppløsning - 20 mg/ dose

Otrivin 0.5 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

otrivin 0.5 mg/ ml

haleon denmark aps - xylometazolinhydroklorid - nesespray, oppløsning - 0.5 mg/ ml

Otrivin 1 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

otrivin 1 mg/ ml

haleon denmark aps - xylometazolinhydroklorid - nesespray, oppløsning - 1 mg/ ml

Otrivin Comp 0.5 mg/ ml / 0.6 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

otrivin comp 0.5 mg/ ml / 0.6 mg/ ml

haleon denmark aps - xylometazolinhydroklorid / ipratropiumbromid - nesespray, oppløsning - 0.5 mg/ ml / 0.6 mg/ ml

Nyxoid ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

nyxoid

mundipharma corporation (ireland) limited - nalokson hydrochloride dihydrat - opioid-relaterte lidelser - alle andre terapeutiske produkter - nyxoid er beregnet til umiddelbar administrasjon som akuttapi for kjent eller mistenkt opioid overdose som manifestert av respiratorisk og / eller sentralnervesystemet depresjon i både ikke-medisinske og helsetjenester. nyxoid is indicated in adults and adolescents aged 14 years and over. nyxoid is not a substitute for emergency medical care.